Home
last updated on 29 March 2021 | reading time approx. 4 minutes
by Christina Gigler
The long-awaited schedules to the agreement in principle on the EU-China Comprehensive Agreement on Investment (CAI) have been released by the European Commission on March 12, 2021. Annexes I and II follow a negative list approach with regards to national treatment, most-favoured nation treatment, prohibited performance requirements and requirements on senior management and boards of directors, whereas Annex III, as schedule of specific commitments and limitations on market access, follows a positive list approach.
Given the ongoing reactions and criticism among the relevant stakeholders, particularly within the European Parliament, it can be expected that the ratification process will be a challenging and time-consuming one. It can be assumed that future events in China will also play a role in ratification, for example with regard to the observance and development of human and labour rights.
With regards to market access, the CAI or rather its schedules generally speaking merely repeat or consolidate already existing commitments of China. There are only very few additional access commitments in key sectors such as automotive and medicine/healthcare, which might have a small but significant impact on foreign investment in China.
The scope of the CAI might be narrower than some investors might have expected. However, one has to bear in mind that the CAI is no free trade agreement, but should rather be put in a broader context of the EU`s overall China strategy.
Sebastian Wiendieck
Partner
Send inquiry
Rödl & Partner in China